- Carlyle exits India's Claris but 'umbrella' plays to see interest?
- PAH drug-device developer SteadyMed prices IPO
- Wockhardt's compliance improving as FDA woes ease?
- USV chief on the metformin 'marathon' & shape of India's diabetes market
ANALYSIS Other Informa Analysis
COMMENT Other Informa Comment
JOB OF THE WEEK Promote your job vacancy